By employing esophageal cancer cell lines in the same study, NRF2 deletion was shown to decrease cell proliferation and increase ROS levels, which led to increased p38 MAPK signaling and decreased expression of CYCLIND1. This evidence concerns the gene NFE2L2 and esophageal cancer.